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A 60-year-old woman with a medical history of inﬁltrative
ductal carcinoma of the right breast underwent breast-conserving
surgery and axillary lymph node dissection, followed by adjuvant
chemotherapy, hormone therapy, and radiotherapy (conventional
radiotherapy, 25 fractions for a total dose of 5000 cGy). Six years af-
ter treatment, asymptomatic skin eruptions on the right side of the
chest and axilla were observed for 4 weeks. The patient was
referred to the dermatology department for suspected cutaneous
metastases. Physical examination revealed multiple discrete pap-
ules, clear ﬂuid-containing vesicles, and lesions with a mild
erythematous base on the right side of the chest. A grayish, rubbery
but compressible cystic nodule, 1.5 cm in diameter, was observed
near the right axillary fossa (Figure 1). No regional lymphedema
or signiﬁcant sclerotic change of the skin was noted. Excisional bi-
opsy of the 1.5-cm cystic nodule was performed.
Histopathological analysis revealed diffuse anastomotic vessels
and dilation of the vascular space, mostly in the deep dermis
(Figure 2A), with concomitant dissection of collagen bundles in
some areas (Figure 2B). In the subcutis, more dilated vascular chan-
nels with stromal projection were observed (Figure 2C). The endo-
thelial cells were plump, discontinuous in a single layer, without
cytologic atypia (Figure 2D). Immunohistochemistry revealed pos-
itive staining for CD31, positive staining for CD34 (Figure 2E), and
negative staining for smooth muscle actin (Figure 2F). A postradia-
tion lymphatic type atypical vascular lesion (AVL) was diagnosed.
The patient decided to forego complete residual lesion removal.
On follow-up, breast cancer recurrence was not noted.
The term AVL was coined by Fineberg and Rosen in 1994.1 They
examined seven patients with breast cancer who had undergone
lumpectomy and adjuvant radiotherapy. Three patients were sub-
sequently diagnosed as having cutaneous angiosarcoma (AS) and
four were diagnosed as having AVLs. Pathologically, AVL is deﬁned
as the proliferation of anastomosed vascular structures with rela-
tive circumscription in the dermis, lined with hyperchromatic
endothelial cells, with stromal projection into the preliminary
lumen, and slight to no dissection of dermal collagen.1 Several re-
ports have conﬁrmed the original description of AVLs.2e4 Other
conditions such as “acquired progressive lymphangioma”, “benign
lymphangiomatous papules”, “lymphangioma circumscriptum”,Conﬂicts of interest: The authors declare that they have no ﬁnancial or non-ﬁnancial
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described as AVLs5; these are now collectively termed as AVLs.
Clinical distinction of AVLs from well-differentiated cutaneous
AS is challenging because their clinical settings and cutaneous mor-
phologies overlap. Postradiation cutaneous AS usually presents as
bruise-like plaques, nodules, indurated skin, and skin ulceration.5,6
In addition, chronic edema may indicate AS, known as a condition
of StewarteTreves syndrome. AVLs often manifest as one or more
skin-colored papules, erythematous to violaceous macules, and
the appearance of clear ﬂuid-containing vesicles or nodules.2,4,6
AS usually arises from thickened mammary skin, often with multi-
ple large lesions1 (median, 7.5 cm), whereas AVLs are smaller (me-
dian, 0.5 cm).2,5 The time period from radiation to the development
of lesions is slightly longer for AS (4e6 years) than for AVL (3e4
years).2,4,6 Dermal anastomosing vessels and hyperchromatic endo-
thelial cells are common features of AVLs and cutaneous AS. How-
ever, AVLs lack the characteristic features of AS such as inﬁltration
into the subcutis, diffuse dissection of collagen bundles, hemor-
rhage with blood lakes, multilayering of endothelial cells, papillary
endothelial hyperplasia, and most importantly, cytologic atypia
including prominent nuclei and mitotic ﬁgures.1,2,4e6Figure 1 A grayish, elastic nodule, measuring 1.5 cm, is seen near the right axillary
fossa. There are multiple vesicles ﬁlled with clear ﬂuid on the right side of the chest.
Some lesions display a mild erythematous base.
n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 2 (A) A low-power photomicrograph showing proliferation of narrow vascular
channels throughout the reticular dermis [hematoxylineeosin staining (H&E), 20].
(B) Anastomotic vessels and dilated vascular space intermixed with mild inﬂammatory
inﬁltration at the deep dermis. Focal dissection of dermal collagen bundles was also
observed (H&E, 200). (C) More dilated vascular channels with small stromal projec-
tions protruding into the lumina at the subcutis level (H&E, 200). (D) A high-power
ﬁeld photomicrograph showing plump, single-layered endothelial cells with no cyto-
logic atypia (H&E, 400). (E) Positive CD34 staining (400). (F) Negative smooth mus-
cle actin staining in the proliferating vessels (400).
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initial report by Fineberg and Rosen1 suggested that they were
distinct entities. However, other studies have suggested the pro-
gression of AVL to AS.2,4 Some histopathological features of mastec-
tomy specimens from patients with AS were indistinguishable from
those of AVL.2,4 These rare reports imply the possibility of a
morphological continuum between AVL and AS. From the view-
point of molecular pathogenesis, Santi et al7 reported that muta-
tional inactivation of the tumor suppressor gene TP53 was found
at similar rates in AVLs (83%) and cutaneous AS (87.5%). Further-
more, a common polymorphism, P72R, was found in both AVL
and AS. These ﬁndings support the hypothesis that AVL and AS
should be biologically related entities.7
Patton et al3 attempted to analyze the risk for developing AS by
interpreting the morphological heterogeneity of AVLs. Immunohis-
tochemical evaluations of lymphatic markers (CD31þ, D2-40þ,
SMA, and CD34þ/) and vascular markers (CD31þ, CD34þ,
SMAþ, and D2-40) were used to describe AVL morphologies.3
Most of the previously described AVLs were lymphatic type-AVLs.
The less commonly observed vascular type (VT-AVL) is more likely
to show cytological atypia and is associated with a higher risk forsubsequent AS development.3 A recent German study further high-
lights thatMYC gene ampliﬁcation is exclusively noted in postradia-
tion AS, but not in postradiation AVLs.8 This ﬁnding could be a
potential diagnostic tool to differentiate the ambiguous lesions of
AVL from AS.
Currently, there are no guidelines for themanagement of postra-
diationAVLs. Themost frequent complication of AVLs is postsurgical
recurrence, rather than transformation to AS, and the development
of new lesions in the same radiation ﬁeld, the so-called “ﬁeld ef-
fect”.9 The incidence of residual or recurrent lesions after variable
extent excision is approximately 20e30%.2,9 Patients with a history
of radiotherapy shouldbe carefullymonitored for vascular eruptions
on the irradiated skin. Once AVL is diagnosed, complete excision
with a negative margin is indicated. Careful surveillance and biopsy
of any clinically suspicious lesion are necessary.
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